Name: Pancreatic Cancer (md Anderson Solid Tumor Oncology Series) (en Inglés)
Price: 282940.00 CLP
Availability: InStock
Author: Lowy Andrew M.|Leach Steven D.|Philip Philip
ISBN: 9781489977618

portada Pancreatic Cancer (md Anderson Solid Tumor Oncology Series) (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Lowy Andrew M.|Leach Steven D.|Philip Philip

Idioma

Inglés

N° páginas

762

Encuadernación

Tapa Blanda

ISBN13

9781489977618

N° edición

Pancreatic Cancer (md Anderson Solid Tumor Oncology Series) (en Inglés)

Lowy Andrew M.|Leach Steven D.|Philip Philip (Autor) · Springer · Tapa Blanda

Libro Nuevo

$ 282.940

$ 471.570

Ahorras: $ 188.630

40% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 21 de Junio y el Lunes 01 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Pancreatic Cancer (md Anderson Solid Tumor Oncology Series) (en Inglés)"

This timely publication brings to the forefront the most recent advances in understanding pancreatic cancer development and successfully treating this dreadful disease. The volume provides information on the recent progress and improvements to date, including developments in molecular events, landmark clinical trials, the first mouse models, and targeted biologic therapies. Since the previous M. D. Anderson Solid Tumor Oncology Series publication on pancreatic cancer, there have been major advances in our understanding of molecular events which underlie pancreatic cancer development, both in the sporadic and inherited forms. We have seen the development of the first mouse models that accurately recapitulate features of the human disease. Several landmark clinical trials in both resectable and metastatic pancreatic cancer have been completed, raising new questions about the standard of care in this disease. Therefore, it is an appropriate time to review these important advances and outline areas of controversy and question in pancreatic cancer biology and treatment.